Malignant hyperthermia. An allergic reaction to thioridazine therapy.
A case of allergic rash associated with malignant hyperthermia (body temperature of 41 C) occurred in a patient who had been taking 400 mg of thioridazine hydrochloride (Mellaril) daily for two days. The condition responded well to supportive measures and immediate discontinuation of the drug use.
D003876:Dermatitis, Atopic / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D008875:Middle Aged; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013881:Thioridazine / Q000009:adverse effects*
D013881:Thioridazine